hematopoietic cell transplantation recipient

Showing 1 - 15 of 15

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (Ixazomib Citrate, Lenalidomide,

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • Plasma Cell Myeloma
  • Ixazomib Citrate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Trial in Duarte (drug, other,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Bone Marrow Transplantation Recipient, Cord Blood Transplant Recipient, Hematopoietic Cell Transplantation Recipient Trial in

Active, not recruiting
  • Bone Marrow Transplantation Recipient
  • +2 more
  • Eltrombopag Olamine
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2022

Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • Plasma Cell Myeloma
  • Elotuzumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Benign Tumor, Bone Marrow Transplantation Recipient, Hematopoietic Cell Transplantation Recipient Trial in Portland (Bone Marrow

Available
  • Benign Neoplasm
  • +3 more
  • Bone Marrow Transplantation
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 9, 2021

Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • +3 more
  • Allogeneic Bone Marrow Transplantation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 18, 2021

Participated in Children's Oncology Group Studies

Recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Assessment of Therapy Complications
  • Questionnaire Administration
  • Birmingham, Alabama
  • +163 more
Sep 3, 2021

GVHD, Hematopoietic Cell Transplantation Recipient Trial in New Brunswick (Dietary Intervention, Laboratory Biomarker Analysis)

Terminated
  • Graft Versus Host Disease
  • Hematopoietic Cell Transplantation Recipient
  • Dietary Intervention
  • Laboratory Biomarker Analysis
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 20, 2021

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Palo Alto (Ibrutinib, Laboratory

Active, not recruiting
  • Acute Biphenotypic Leukemia
  • +4 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jan 28, 2021

Acute Leukemia in Remission, Hematopoietic Cell Transplantation Recipient, Lymphoma Trial in Seattle (Monitoring Device,

Completed
  • Acute Leukemia in Remission
  • +2 more
  • Monitoring Device
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2020

Hematopoietic Cell Transplantation Recipient Trial in Seattle (Booklet, Exercise Intervention, Quality-of-Life Assessment)

Completed
  • Hematopoietic Cell Transplantation Recipient
  • Booklet
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 2, 2020

Hematopoietic Cell Transplantation Recipient, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus

Withdrawn
  • Hematopoietic Cell Transplantation Recipient
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 19, 2020

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (Platelet Transfusion)

Terminated
  • Acute Biphenotypic Leukemia
  • +13 more
  • Platelet Transfusion
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2019

Hematopoietic and Lymphoid Cell Tumor, Hematopoietic Cell Transplantation Recipient Trial in Duarte (procedure, drug, other,

Withdrawn
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Hematopoietic Cell Transplantation Recipient
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Dec 5, 2018

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid

Withdrawn
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +11 more
  • Multi-antigen CMV-Modified Vaccinia Ankara Vaccine
  • +2 more
  • Duarte, California
  • +2 more
Nov 19, 2018